Science
CRISPR Epigenome Editing Restores Vision in Groundbreaking Clinical Trial for Inherited Retinal Diseases
Single-dose in vivo epigenetic therapy successfully reactivated dormant photoreceptor genes in 85% of clinical trial patients with zero off-target genomic alterations.